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P lasma cell dyscrasias such as multiple myeloma(MM) result from clonal proliferation of plasma cells
and subsequent overproduction of Igs, including free
light chains. Renal dysfunction is a core manifestation of
plasma cell dyscrasias. A broad range of kidney pa-
thologies can occur, including light chain cast ne-
phropathy, monoclonal Ig deposition disease, light
chain amyloidosis, light chain proximal tubulopathy,
and tubulointerstitial nephritis.1–3
Light chain proximal tubulopathy (LCPT) is a rare
manifestation of monoclonal gammopathy and is char-
acterized by the accumulation of monotypic light
chains within the proximal tubule epithelial cells. The
accumulated light chains frequently form crystals;
however, noncrystalline forms of LCPT have been
described.4,5 LCPT with crystals is associated with a
kappa light chain in the vast majority of cases, which is
discovered by either routine immunoﬂuorescence (IF),
IF, or immunohistochemistry after protease digestion of
the parafﬁn-embedded tissue. LCPT without crystals
can be seen with both kappa- and lambda-restricted
disease. When crystals are present, ultrastructural ex-
amination is often essential to the diagnosis as crystals
may be easily missed by light microscopy. The diag-
nosis of LCPT is of great clinical importance. In up to
85% of patients, kidney biopsy showing LCPT is the
initial clue to an underlying plasma cell dyscrasia
before a diagnosis has been established or the disease
has come to clinical attention.5 Therefore, the diagnosis
of LCPT is crucial for appropriate patient management.
We report an unusual case of LCPT in a 59-year-old
woman associated with lambda light chain restriction
with prominent intraluminal crystalline casts.
CASE PRESENTATION
A 59-year-old Caucasian woman presented with
weakness, fatigue, and acute kidney injury with signsof marked dehydration. She had a history of left-sided
nephrectomy 6 years ago due to a large staghorn cal-
culus. Fifteen months before presentation, she was
diagnosed with MM after presenting with anemia, fa-
tigue, multiple lytic bone lesions, and serum protein
electrophoresis showing an M-spike with monoclonal
IgA lambda. Bone marrow biopsy revealed 90% clonal
plasma cells with a high-risk cytogenetic proﬁle. She
was treated with bortezomib, dexamethasone, and
lenolidomide with good response and bone marrow
biopsy 6 months after her initial diagnosis showed no
residual myeloma; however, positron emission tomog-
raphy scan demonstrated persistent bony disease.
At the time of her acute presentation, serum creati-
nine was 3.8 mg/dl with an estimated glomerular
ﬁltration rate of 13 ml/min per 1.73 m2 calculated by
the 4-variable Modiﬁcation of Diet in Renal Disease
study equation. Quantitative urine protein measure-
ments revealed nephrotic-range proteinuria with 4 g
per 24 hours. Urine electrolyte studies were not per-
formed. I.v. ﬂuid resuscitation failed to improve her
renal function, and because of signiﬁcant proteinuria
and concern over persistent MM, kidney biopsy was
performed.
Kidney Biopsy
Twenty glomeruli were sampled, all of which were
patent and without signiﬁcant pathologic alterations.
Proximal tubules demonstrated diffuse loss of brush
borders, extensive cytoplasmic vacuolization, and
sloughing of cell cytoplasm into tubular lumina.
Focally, proximal tubular epithelial cells showed
prominent intracytoplasmic inclusions, some of which
were sharply demarcated and rhomboid in appearance
(Figure 1a). These inclusions were brightly eosinophilic
on the hematoxylin and eosin stain, pale on the peri-
odic acid Schiff stain, and fuschinophilic on the
trichrome stain (Figure 1b). In addition, tubules
frequently showed large intraluminal collections ofKidney International Reports (2016) 1, 316–320
Figure 1. (a) Proximal tubules show prominent injury with coarse cytoplasmic vacuolization and brightly eosinophilic intracytoplasmic
inclusions (hematoxylin and eosin). (b) Intracytoplasmic inclusions were fuschinophilic on the trichrome stain (trichrome). (c) Numerous
intraluminal casts were seen, some of which showed a ﬁne ﬁbrillary structure (hematoxylin and eosin), whereas (d) others demonstrated
needle-like and rhomboid crystals (trichrome). Immunohistochemical stains for a (e) lambda light chain and (f) kappa light chain highlighted
prominent light chain restriction within luminal casts and cytoplasmic material.
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which were associated with an inﬂammatory reaction
(Figure 1c and d). There was no birefringence under
polarized light. There was a diffuse and mixed inter-
stitial inﬂammatory inﬁltrate consisting primarily of
mononuclear cells with scattered neutrophils and rare
eosinophils. The degree of interstitial ﬁbrosis and
tubular atrophy was moderate, involving up to 40% to
50% of the sample. Mild chronic vascular disease was
observed without features of arteritis.Kidney International Reports (2016) 1, 316–320By direct IF microscopy, there was no glomerular
staining for IgG, IgA, IgM, C3, C1q, kappa light chain,
lambda light chain, ﬁbrinogen, or albumin. The intra-
tubular casts and cytoplasmic inclusions showed
weak staining for a lambda light chain without staining
for a kappa light chain. Because of weak staining,
immunohistochemical studies for kappa and lambda
light chains were performed, which revealed strong
staining of the intratubular and intracytoplasmic ma-
terial for the lambda light chain without staining for317
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examination of glomeruli showed no abnormalities.
The evaluation of the tubules revealed abundant
intraluminal crystalline structures with both needle-
like and rhomboid conﬁguration (Figure 2a). Focally,
proximal tubular epithelial cells showed large pro-
minent electron dense inclusions (Figure 2b).
Overt crystal formation was not seen within proximal
tubular cells. Substructural organization was not
observed.
Biopsy Diagnosis
The biopsy was interpreted as acute tubular injury
and/or necrosis with light chain crystalline cast ne-
phropathy and proximal tubulopathy (lambda light
chain restricted).
Clinical Follow-up
After her acute presentation and kidney biopsy ﬁnd-
ings, the patient deferred further therapy for her MM
and initiated comfort care. She subsequently passed
away from her disease 16 days after kidney biopsy was
performed.DISCUSSION
Light chain proximal tubulopathy is a rare manifes-
tation of MM that results from both overproduction
and abnormal production of light chains by neoplastic
plasma cells. Prior studies have shown an estimated
biopsy incidence of 0.5% to 5% in patients with a
monoclonal gammopathy.3–5 Under normal condi-
tions, proximal tubular epithelial cells reabsorb
small volumes of free light chains through the megalin
and/or cubulin receptor, which are endocytosed
and trafﬁcked to the lysosomes for degradation.6 In
patients with paraproteinemia, the reabsorptiveFigure 2. (a) Ultrastructural examination revealed abundant intraluminal
dense inclusions were present within proximal tubular epithelial cells.
318capacity of the proximal tubules may be overwhelmed
by the increased volume of light chains, leading to
Bence-Jones proteinuria and accumulation of patho-
genic light chains within proximal tubule epithelial
cells. Also contributing to the disease process are
atypical biochemical properties of these light chains.
The light chain variable domain is impervious to
breakdown by lysosomal enzymes, which leads to
accumulation in renal tubular epithelial cells.7,8
Furthermore, these abnormal light chains can have
an intrinsic propensity to crystallize.9 Light chain
crystals can also accumulate in other cell types such as
podocytes and macrophages, disease processes termed
light chain podocytopathy and crystal storing histio-
cytosis, respectively.10–12
In addition, crystalline cast nephropathy can be a
complication of plasma cell dyscrasias and has only
rarely been reported in the setting of LCPT. In most
cases, the crystalline casts take on similar morphologic
features to the intracytoplasmic crystals.5 In the
described case, overt crystal formation was not seen
within proximal tubular cells; however, widespread
crystalline casts were seen obstructing distal tubules.
This combination of ﬁndings shows the dynamic na-
ture of these particular pathogenic light chains with
crystallization in distal nephron segments, likely owing
to alterations in the surrounding milieu and interaction
with uromodulin (Tamm-Horsfall protein).
Crystalline LCPT is almost exclusively seen in
kappa-restricted disease with only rare examples of
lambda-restricted intracytoplasmic crystals.4,13 The
presence of crystalline casts is regarded as uncommon
in LCPT and their presence is typically only a focal
ﬁnding. Haider et al.14 reported a patient with acute
kidney injury resulting from lambda-restricted intra-
luminal crystalline casts; however, concurrent LCPT
was not observed.crystalline casts. (b) Focally, prominent intracytoplasmic electron
Kidney International Reports (2016) 1, 316–320
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these cases are more likely to be lambda restricted than
crystalline LCPT. Noncrystalline LCPT may result from
light chains that do not have the biochemical pro-
pensity to crystallize.4,5 In some cases without crystals
(particularly those without clinical evidence of kidney
injury or Fanconi syndrome), the light chain accumu-
lation may simply be due to physiological uptake by
proximal epithelial cells and may not represent patho-
genic tubular injury.
The diagnosis of LCPT can be challenging, and is
made by the identiﬁcation of light chain-restricted
intracytoplasmic inclusions within the proximal tu-
bule epithelial cells, which may be quite focal.5 They
typically stain brightly eosinophilic on the hematoxy-
lin and eosin stain, pale on the periodic acid Schiff
stain, and fuschinophilic on the trichrome stain. In the
largest series of such cases, Stokes et al. reported
46 cases of LCPT (40 with crystals and 6 without). All
40 cases with crystals were kappa light chain
restricted, whereas 2 of 6 noncrystalline forms were
lambda light chain restricted. Nine cases demonstrated
intraluminal crystalline casts, which were only focally
present, and were associated with crystalline LCPT.5
Larsen et al. reported 13 patients with light chain
proximal tubulopathy. One patient with lambda-
restricted disease showed rare intracytoplasmic
crystals by electron microscopy, and intraluminal
crystalline casts were not mentioned.4
When evaluating a biopsy with prominent intra-
luminal casts or crystals, the differential diagnosis is
broad. Intraluminal casts that stain brightly eosino-
philic on the hematoxylin and eosin stain include cases
of light chain cast nephropathy, myoglobinuric- or
hemoglobinuric-associated tubular injury, casts associ-
ated with mechanistic target of rapomycin (mTOR)
inhibitory toxicity, and bile cast nephropathy.15–18
Intraluminal crystals can be seen in a wide variety of
conditions including primary or secondary oxalosis,
phosphate nephropathy, drug toxicity (particularly
foscarnet and indinavir), and 2,8 dihydroxyadeninuria.
In the case of oxalosis, the crystals are typically rhom-
boid in shape, yellow in color, and are birefringent
under polarized light. Crystals associated with foscarnet
and indinavir are best seen on frozen sections and are
also polarized. On electron microscopy, these crystals
appear as cleared out spaces, unlike the markedly elec-
tron dense crystals seen in light chain-associated dis-
ease. The crystals of 2,8 dihydroxyadeninuria are often
brown in color, needle to rhomboid in shape, and are
birefringent when viewed under polarized light.19–21
In LCPT, IF studies may highlight light chain
restriction in the proximal tubule epithelial cells. In
cases with crystals, routine IF microscopy on frozenKidney International Reports (2016) 1, 316–320tissue may show false-negative results. In such cases,
utilization of IF on parafﬁn-embedded tissue after
digestion with protease better highlights the light
chain restriction.22 Immunohistochemical studies can
also be useful, as in our case. Electron microscopy is of
paramount importance in cases of LCPT and can
highlight intracytoplasmic and intraluminal electron
dense crystalline structures as well as enlarged atypical
lysosomes. Occasionally, substructural organization,
such as paracrystalline arrays, can be seen.5
Clinically, patients with LCPT may present with
acquired Fanconi syndrome characterized by normo-
glyemic glycosuria, aminoaciduria, hyperphosphaturia,
and type II renal tubular acidosis.5,8,23 Slowly pro-
gressive chronic renal failure may occur and recurrence
after transplant has been reported.24 The International
Kidney and Monoclonal Gammopathy Research Group
recommends chemotherapy or stem cell transplant
for LCPT even before worsening hematologic disease
occurs.25 Treatment of the underlying plasma cell
dyscrasia in patients with LCPT has shown varying
results with a minority in one study showing complete
response, while most patients had stable hematologic
disease. Kidney function showed a general trend to-
ward improvement in patients who were treated either
with chemotherapy alone or with chemotherapy and
stem cell transplantation.5 Furthermore, renal involve-
ment is an independent predictor of poor outcomes in
MM,26 and the early identiﬁcation of LCPT may help
stratify risk and drive patient management.
In summary, LCPT is a rare but important ﬁnding on
renal biopsy and requires a high index of suspicion and
thorough investigation of the sample, often including
immunohistochemical studies or IF after protease
digestion on the parafﬁn-embedded tissue. Correct
diagnosis is crucial in driving proper patient manage-
ment including chemotherapy and/or stem cell trans-
plant for both control of the hematologic process and
treatment of kidney disease, particularly in patients
who require transplantation.
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